UndernutritionPROTEINNCT05309759
Impact of Undernutrition Definitions on Its Prevalence in Hospitalized Patients
An observational study of Undernutrition, run by Hopital Forcilles at 1 site in France.
Trial summary
In France, the prevalence of undernutrition among hospitalized patients varies from 30 to 50%. Undernutrition is strongly associated with a decrease in the patient's functional capacities and an increase in morbidity and mortality and in healthcare costs. Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Undernutrition
- How many people
- 260 participants
- Where
- 1 siteFrance
- Study dates
- 10 Feb 2022to 10 Feb 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients will be recruited prospectively and consecutively from the departments of diabetes-obesity, pneumology, oncology and gastro-nutrition at the Forcilles Hospital. The dietician of the unit identifies the patients on admission to the department.
Who may be able to join
- Admitted to diabetes-obesity, pneumology, oncology and gastro-nutrition departments;
- Age between 18 and 70 years at the time of inclusion ;
- Affiliation with a social security scheme or beneficiary of such a scheme ;
- Oral, free, informed and express consent of the patient.
Who cannot join
- Inability to perform bioelectrical impedance measurement ;
- Incapacity to consent ;
- Patient's refusal to participate in the study ;
- Known pregnancy ;
- Person subject to a legal protection measure ;
- Patient under guardianship or curatorship ;
- Patient with limited care ;
- Randomisation in the ineligible study group.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Impact of the French and International Definitions and the Type of Muscle Assessment Tool on the Prevalence of Undernutrition in Hospitalized Patients
In France, the prevalence of undernutrition among hospitalized patients varies from 30 to 50%. Undernutrition is strongly associated with a decrease in the patient's functional capacities and an increase in morbidity and mortality and in healthcare costs.
In 2019, the Global Leadership Initiative on Malnutrition (GLIM) and the Haute Autorité de Santé (HAS) are each publishing updated diagnostic criteria for undernutrition in adults aged <70 years. Aetiological and phenotypic criteria are retained: reduced food intake, inflammatory state, weight loss, BMI and reduced muscle mass. Reduced muscle mass has become a major diagnostic criterion and various measurement tools are suggested, such as bioelectrical impedancemetry, grip strength measurement or magnetic resonance imaging. Collaboration between dieticians, physiotherapists, nurses, care assistants and doctors makes it possible to respond to the need to screen for undernutrition according to these new definitions, which involve a multidisciplinary assessment.
Read more
These two definitions are very similar but differ on the time period of weight loss, on the BMI cut-off values and on the thresholds for muscle mass loss. The GLIM definition may be less selective than the HAS definition.
The investigators hypothesise that the prevalence of undernutrition in a population of adult patients hospitalised in diabetology-obesity, pneumology, oncology and gastro-nutrition, aged < 70 years, is different according to the diagnostic criteria recommended by the HAS or by the GLIM, and may be associated with a different patient morbi-mortality. In addition, the choice of the method of assessment of muscle function could impact this prevalence.
The main objective of this study is to compare the prevalence of global undernutrition based on the diagnostic criteria recommended by the HAS with that based on the diagnostic criteria recommended by the GLIM, in patients hospitalised in diabetes-obesity, pneumology, oncology and gastro-nutrition units.
The secondary objectives will be, in patients hospitalized in diabetes-obesity, pneumology, oncology and gastro-nutrition units:
- To compare the prevalence of severe undernutrition between the HAS and GLIM groups;
- To compare the morbi-mortality of undernutrition between the HAS and GLIM groups on :
- Length of hospital stay ;
- Mortality rate;
- Autonomy at discharge.
- To evaluate the impact of the choice of the muscle function assessment tool on the prevalence of undernutrition in the HAS and GLIM groups.
This is a prospective, monocenter, observationnal and cohort study.
Patients hospitalised in acute and rehabilitation care for diabetes-obesity, pneumology, oncology and gastro-nutrition purpose.
Univariate comparisons will use the usual statistical tests after verification of the distribution of the variables (Chi2 or Fisher's test, t-test, anova or their non-parametric equivalents Wilcoxon and Kruskal-Wallis tests). The variables will be compared between the two groups by the appropriate tests according to the type of variables (quantitative or qualitative) and their distribution.
The results of this study will make it possible to verify whether the GLIM definition increases the prevalence of undernutrition compared to that of the HAS. The use of one or other of the definitions could thus have an impact on the medical and paramedical management of undernutrition. On the other hand, muscle function benefits from different assessment tools, which could lead to a different estimate of the reduction in muscle mass and therefore a different prevalence of undernutrition. The results of our study will help to evaluate this and guide professionals in the choice of tools for assessing muscle function.
Read the detailed description
- Rationale 1.1 Epidemiology and morbidity of undernutrition Undernutrition, whether related to disease, poverty, hunger, war or natural disasters, affects more than one billion people worldwide (1). In France, an empirical estimate suggests a prevalence of undernutrition among hospitalized patients next to 2 million or 30 to 50%. It should be underligned that undernutrition is very common in and out of hospital. It is widely accepted that undernutrition can be caused by a deficit in nutrient intake or malabsorption. However, it is now known that the presence of an inflammatory state during illness is associated with undernutrition (1). The inflammatory state leads to anorexia and decreased intake but also increases basal metabolic rate and muscle catabolism. Undernutrition is marked by a decrease in all markers of muscle mass (1). Thus, It is strongly associated with a decrease in the patient's functional capacity and an increase in morbidity and mortality and health care costs (1,4-6). 1.2 International consensus on the definition of undernutrition In 2019, the Global Leadership Initiative on Malnutrition (GLIM) published an international consensus report on the diagnostic criteria for undernutrition (1). The diagnostic criteria are numerous, and include aetiological criteria such as reduced food intake; inflammatory context; symptoms such as anorexia, weakness; phenotypic criteria such as weight loss, body mass index (BMI), fat to lean mass ratio, fluid retention and muscle function. Muscle mass is described as a major diagnostic criterion, since it is a direct indicator of protein catabolism linked to undernutrition, but also a reflection of patient functional impairment, as it is directly associated with functional capacity, autonomy and prognosis. Various measurement tools are suggested, such as bioelectrical impedancemetry, ultrasound or magnetic resonance imaging, giving the tool choice by the clinicians, depending on experience and local resources. Handgrip measurement is considered as a complementary measure. GLIM advises an assessment of the risk of undernutrition, using validated questionnaires such as the NRS (Nutritional Risk Screening) or the MNA-SF (Mini Nutritional Assessment-Short Form). 1.3 New definition of undernutrition in France The French National Authority for Health (HAS) revised the definition of undernutrition in adults (< 70 years) in 2019, which is very similar to, but differs in some important aspects, from the GLIM definition. It includes the use of aetiological and phenotypic criteria, and now includes the assessment of muscle strength, gait speed and bioelectrical impedancemetry. 1.4 Convergences and divergences between the international and French definitions In adults under 70 years of age, both the GLIM and the HAS recommend screening for undernutrition, but the HAS recommendations do not recommend the use of a precise tool for assessing the risk of undernutrition. The presence of at least one aetiological criterion and one phenotypic criterion is mandatory to make a diagnosis of undernutrition in both situations. The differences between the international consensus and the HAS recommendations concern the diagnostic criteria. 1.5 Assessment of muscle function Physiotherapists use different tools to assess different aspects of muscle function, such as strength or walking speed. Isometric grip strength is strongly correlated with lower limb muscle strength, and is a negative marker of mobility in case of weakness (14). A linear relationship has been observed between grip strength and patient disability as measured by the Katz independence scale. In addition, grip strength has been shown to be a good predictor of the patient's clinical condition (19). The measurement of grip strength, using a dedicated dynamometer, also has the advantage of being simple and reliable and has reference values adjusted for gender and BMI. Gait speed is another indicator used to assess muscle function. It is associated with lower limb strength and is a predictor of disability and mobility limitation (14). Usual walking speed is most often measured over a distance of 4 or 6 m and has reference values adjusted for gender and height (19). Dietitians are also involved in the assessment of muscle function by measuring body composition in terms of lean body mass and fat mass. They perform bioelectrical impedancemetry, which estimates the volumes of fat and lean body mass by measuring the resistance of biological tissues to a low-intensity, high-frequency sinusoidal electric current through electrodes (14). This measurement method is simple to use, inexpensive, reproducible and feasible in bedridden patients (14). It also correlates very well with MRI and reference values are obtained in a variety of adult populations (12,22). 1.6 Research hypothesis The investigators hypothesise that the prevalence of undernutrition in a population of patients hospitalised in diabetology-obesity, pneumology, oncology and gastro-nutrition, under 70 years of age is different according to the diagnostic criteria recommended by the French National Authority for Health or those recommended by the Global Leadership Initiative on Malnutrition. Moreover, these two definitions could have a different impact on patient morbidity and mortality. The choice of the method of assessment of muscle function could impact on this prevalence.
- Objective 2.1 Main objective The main objective of this study is to compare the prevalence of global undernutrition based on the diagnostic criteria recommended by the French National Authority for Health with that based on the diagnostic criteria recommended by the Global Leadership Initiative on Malnutrition, in patients hospitalised in diabetology-obesity, pneumology, oncology and gastro-nutrition 2.2 Secondary objectives The secondary objectives will be, in patients hospitalised in diabetes-obesity, pneumology, oncology and gastro-nutrition units:
- To compare the prevalence of severe undernutrition according to the HAS and GLIM diagnostic criteria;
- To compare the morbi-mortality of moderate and severe undernutrition according to the HAS and GLIM diagnostic criteria:
- Length of hospital stay ;
- Mortality rate ;
- Autonomy at discharge.
- To compare the predictive capacity of muscle function assessment tools on undernutrition according to the HAS and GLIM diagnostic criteria.
- Type of study This is a prospective, monocenter, obversational cohort study. The research will be conducted in accordance with the protocol. The duration of recruitment will be 20 months with follow-up of patients during their entire hospital stay in the care unit, i.e. approximately 30 days (average length of stay), i.e. a total duration of the study estimated at 21 months. The study will take place at the Forcilles Hospital, in diabetology-obesity, pneumology, oncology and gastro-nutrition units.
- Usual assessment procedures 4.1 Nutritional assessment At the patient's admission, a nutrition assessment is carried out by the dietician following the recommendations issued by the French Association of Dieticians-Nutritionists (AFDN) and the HAS. The dietician collects all the data required to detect malnutrition, such as weight, height, BMI, albumin levels, as well as grip strength and walking speed (carried out by the care assistant and the physiotherapist). The dietician also looks for possible obstacles to feeding, such as dental condition, swallowing problems or digestive discomfort. The doctor looks for various pathologies affecting digestive absorption such as short stool syndromes, gastrectomies, pancreatic insufficiency etc. It also looks for factors of aggression such as cancer, chronic progressive diseases, infections etc. All of this data is used to estimate the patient's theoretical nutritional needs and to adapt the nutritional management. The dietician, in collaboration with the nurses' aides, monitors the patient's intake. 4.2 Anthropometric measurements When the patient is admitted, the nurses measure the patient's weight and height. If the patient can maintain the erect position, a conventional scale and a measuring rod are used for the measurements. If the patient cannot maintain this position, a weighing chair and a laser meter are used. In order to assess weight loss prior to hospitalisation, the previous weight is sought from a hospital report or other recent medical document. Contact with the attending physician is also made in order to obtain information about the patient's weight history. If this information is not available, the patient's previous weight is collected. 4.3 Biological measurements On admission, a biological sample is usually taken from patients at risk of undernutrition in order to measure pre-albumin, albumin and C-reactive protein (CRP). These elements make it possible to determine the severity of undernutrition when it is present, according to the diagnostic criteria of the HAS. 4.4 Muscle function measurements Measurement of grip strength ("Handgrip") 4.5 Gait speed measurement
- Assessment procedure added by the research 5.1 Mini-Nutritional Assessment Short Version (MNA-SF) score 5.2 Bio-electrical impedance measurement 5.3 Diagnosis of undernutrition according to GLIM criteria The diagnosis of undernutrition will also be carried out in the framework of this research according to the GLIM criteria. It will be based on the search for at least 1 phenotypic criterion and 1 etiological criterion. Severe undernutrition will be based solely on phenotypic criteria. This diagnosis according to the GLIM definition will be made by one of the investigators not involved in the management of the patient. The patient's team will be blinded to these results so as not to influence the management of the patient.
5 Statistical aspects 5.1 Calculation of the number of subjects required According to our internal epidemiological data, the prevalence of undernutrition according to the HAS definition was 34%. Taking into account the wider period of weight loss and the higher BMI threshold used by GLIM in its definition of undernutrition, the investigators estimate a higher prevalence of undernutrition. In the absence of data in the literature, the investigators estimate a prevalence of undernutrition according to the GLIM definition at 49%, and a difference of at least 15%. The investigators wish to highlight this discordance. With a risk α = 0.05 and a power of 80%, it will be necessary to include 260 patients.
5.2 General aspects Descriptive statistics will be based on means (+/- standard deviation) or medians [interquartile range] depending on the distribution of quantitative variables. Categorical variables will be described in terms of numbers and percentages. Univariate comparisons will use the usual statistical tests after checking the distribution of the variables (Chi2 or Fisher's test, t-test, anova or their non-parametric equivalents Wilcoxon and Kruskal-Wallis tests). Paired-sample tests will be used if necessary.
Tests will be performed at the 5% significance level. The 95% confidence intervals will be provided for each estimate.
Calculations will be made using IBM SPSS v21 and R software (version 3.6.1, http://www.R-project.org ).
5.3 Main objective The difference in the prevalence of global undernutrition between the HAS and GLIM groups will be compared using the McNemar test for comparison of proportions in matched samples.
5.4 Secondary objectives 5.4.1 Comparison of the prevalence of severe undernutrition The difference in the prevalence of severe undernutrition between the HAS and GLIM groups will be compared using the test described in the primary objective.
5.4.2 Comparison of morbidity and mortality Morbidity and mortality will be compared between the HAS and GLIM groups, for moderate and severe undernutrition, by comparing length of hospital stay, mortality and independence at discharge.
Length of hospital stay There is a relationship between the incidence of mortality and all duration type variables. Length of stay will therefore be analysed using a competitive risk method, which allows for the fact that patients who die are no longer eligible for length of stay analysis (25).
The estimator also provides the probability of in-hospital death, so that the probability of hospital discharge versus death can be assessed simultaneously at any time after inclusion in the study.
Mortality rates Mortality rates will be estimated using the Kaplan and Meier method. Comparison of the 2 curves will be performed by a Logrank test. The mortality rates in the 2 groups will be estimated via the survival curves.
ADL The ADL score will be compared between the 2 groups using the discrete numerical variable comparison tests described in the general aspects.
5.4.3 Comparison of muscle function assessment tools The impact of the choice of muscle function assessment tool will be assessed by comparing the prevalences of undernutrition diagnosed by each tool and by comparing the presence of reduced muscle mass by each tool.
6 Expected results in terms of scientific and professional advances The results of this study will make it possible to verify whether the GLIM definition increases the prevalence of undernutrition compared to that of the HAS. The use of one or other of the definitions could have an impact on the medical management of undernutrition. On the other hand, muscle function benefits from various assessment tools. These tools assess different aspects of the muscle, such as strength, functional performance or quantity. Muscle function has an important place in the new definitions of undernutrition, involving physiotherapists in addition to dieticians, nurses, care assistants and physicians in the screening for undernutrition. The different tools could lead to a different estimation of the reduction of muscle mass and thus a different prevalence of undernutrition. The results of our study will help to evaluate this and guide professionals in the choice of tools for assessing muscle function.
7 Expected benefits and risks for patients 7.1 Minimal risks and constraints added by the research All medical examinations and management are usually carried out with the exception of the MNA-SF questionnaire and bioelectrical impedancemetry, which will be carried out systematically in the patients included. The MNA-SF questionnaire is very quick (less than 5 minutes) and therefore causes very little inconvenience to the patient apart from an additional visit by a carer. Bioelectrical impedancemetry is a tool for assessing body composition using electrodes applied to the skin surface. The examination takes an average of 15 minutes, and is non-invasive and painless. The minimal stress is related to the placement of the electrode and the duration of the examination.
7.2 Expected benefits for the patient This study may highlight a difference in the prevalence of undernutrition according to the definitions and tools used. The results of this study will not provide direct benefits for the patient, but could allow the clinician to be more vigilant if undernutrition is underestimated, according to the criteria used in France. The benefit would then be a broader screening of undernutrition and would allow the adaptation of the patient's nutritional and rehabilitation management.
- Conditions
- Undernutrition
- Keywords
- undernutrition, muscle assessment, diagnostic
- Medical subject headings
- Malnutrition, Disease
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of global undernutrition
The main outcome is the prevalence of global undernutrition in patients hospitalised in diabetes-obesity, pneumology, oncology and gastro-nutrition departments, according to the diagnostic methods of the HAS and GLIM.
Measured: Through study completion, an average of 20 months
Secondary outcomes (7)
Prevalences of severe undernutrition
Prevalences of severe undernutrition according to the HAS and GLIM diagnostic methods
Measured: Through study completion, an average of 20 months
Duration of hospital stay
Duration of hospital stay (days) related to moderate and severe undernutrition according to the HAS and GLIM diagnostic criteria.
Measured: Through study completion, an average of 20 months
Mortality
Mortality related to moderate and severe undernutrition according to the HAS and GLIM diagnostic criteria :
- Mortality: proportion and date of occurrence of death among patients included during hospitalisation.
Measured: Through study completion, an average of 20 months
Autonomy at discharge
Autonomy at discharge related to moderate and severe undernutrition according to the HAS and GLIM diagnostic criteria.
Autonomy at discharge will be assessed by the Activities Daily Living score (ADL). This score range from 0 (worse outcome) to 6 (better outcome).
Measured: Through study completion, an average of 20 months
Bioelectrical impedance measurement
Bioelectrical impedance measurement (muscle mass index, Kg/m2)
Measured: Through study completion, an average of 20 months
Muscle force
Muscle force will be assessed by the Handgrip with the JAMAR dynamometer (Kg).
Measured: Through study completion, an average of 20 months
Walking speed
Walking speed (m/s) will be assessed using a 4-meter course, in a corridor.
Measured: Through study completion, an average of 20 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Apr 2022
- Study start10 Feb 2022
- Primary completion2 Oct 2025
- Study completion10 Feb 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for UndernutritionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 260 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hopital Forcilles
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Virginie COLELLA, MSc, Principal investigator, Hopital ForcillesIlham BENHARRATS, MD, Study director, Hopital ForcillesAymeric LE NEINDRE, PhD, Study chair, Hopital Forcilles
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05309759
- Sponsor's protocol ID
- 2021-A02410-41
- Acronym
- PROTEIN
- Status last verified
- Sep 2026
- First submitted
- 15 Mar 2022
- Last updated
- 21 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The protocole, the statistical analysis plan and data will be available as supplementary materials with the publication. The other data that support the findings of this study will be available from the corresponding author upon reasonable request.
Publications
Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats A, Crivelli A, Evans DC, Gramlich L, Fuchs-Tarlovsky V, Keller H, Llido L, Malone A, Mogensen KM, Morley JE, Muscaritoli M, Nyulasi I, Pirlich M, Pisprasert V, de van der Schueren MAE, Siltharm S, Singer P, Tappenden K, Velasco N, Waitzberg D, Yamwong P, Yu J, Van Gossum A, Compher C; GLIM Core Leadership Committee; GLIM Working Group. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019 Feb;38(1):1-9. doi: 10.1016/j.clnu.2018.08.002. Epub 2018 Sep 3.
PubMed 30181091Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr. 2003 Jun;22(3):235-9. doi: 10.1016/s0261-5614(02)00215-7.
PubMed 12765661Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
PubMed 20392703
Study at a glance
From the registry record, last updated by the sponsor on 21 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of the French and International Definitions and the Type of Muscle Assessment Tool on the Prevalence of Undernutrition in Hospitalized Patients
- ClinicalTrials.gov ID
- NCT05309759
- Acronym / sponsor ID
- PROTEIN / 2021-A02410-41
- Conditions
- Undernutrition
- Keywords
- undernutrition, muscle assessment, diagnostic
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 260 participants (actual)
- Lead sponsor
- Hopital ForcillesUniversity, hospital or other
- Study start
- 10 Feb 2022 (actual)
- Primary completion
- 2 Oct 2025 (actual)
- Study completion
- 10 Feb 2026 (actual)
- First posted
- 4 Apr 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In France, the prevalence of undernutrition among hospitalized patients varies from 30 to 50%. Undernutrition is strongly associated with a decrease in the patient's functional capacities and an increase in morbidity and mortality and in healthcare costs.
In 2019, the Global Leadership Initiative on Malnutrition (GLIM) and the Haute Autorité de Santé (HAS) are each publishing updated diagnostic criteria for undernutrition in adults aged <70 years. Aetiological and phenotypic criteria are retained: reduced food intake, inflammatory state, weight loss, BMI and reduced muscle mass. Reduced muscle mass has become a major diagnostic criterion and various measurement tools are suggested, such as bioelectrical impedancemetry, grip strength measurement or magnetic resonance imaging. Collaboration between dieticians, physiotherapists, nurses, care assistants and doctors makes it possible to respond to the need to screen for undernutrition according to these new definitions, which involve a multidisciplinary assessment.
These two definitions are very similar but differ on the time period of weight loss, on the BMI cut-off values and on the thresholds for muscle mass loss. The GLIM definition may be less selective than the HAS definition.
The investigators hypothesise that the prevalence of undernutrition in a population of adult patients hospitalised in diabetology-obesity, pneumology, oncology and gastro-nutrition, aged < 70 years, is different according to the diagnostic criteria recommended by the HAS or by the GLIM, and may be associated with a different patient morbi-mortality. In addition, the choice of the method of assessment of muscle function could impact this prevalence.
The main objective of this study is to compare the prevalence of global undernutrition based on the diagnostic criteria recommended by the HAS with that based on the diagnostic criteria recommended by the GLIM, in patients hospitalised in diabetes-obesity, pneumology, oncology and gastro-nutrition units.
The secondary objectives will be, in patients hospitalized in diabetes-obesity, pneumology, oncology and gastro-nutrition units:
- To compare the prevalence of severe undernutrition between the HAS and GLIM groups;
- To compare the morbi-mortality of undernutrition between the HAS and GLIM groups on :
- Length of hospital stay ;
- Mortality rate;
- Autonomy at discharge.
- To evaluate the impact of the choice of the muscle function assessment tool on the prevalence of undernutrition in the HAS and GLIM groups.
This is a prospective, monocenter, observationnal and cohort study.
Patients hospitalised in acute and rehabilitation care for diabetes-obesity, pneumology, oncology and gastro-nutrition purpose.
Univariate comparisons will use the usual statistical tests after verification of the distribution of the variables (Chi2 or Fisher's test, t-test, anova or their non-parametric equivalents Wilcoxon and Kruskal-Wallis tests). The variables will be compared between the two groups by the appropriate tests according to the type of variables (quantitative or qualitative) and their distribution.
The results of this study will make it possible to verify whether the GLIM definition increases the prevalence of undernutrition compared to that of the HAS. The use of one or other of the definitions could thus have an impact on the medical and paramedical management of undernutrition. On the other hand, muscle function benefits from different assessment tools, which could lead to a different estimate of the reduction in muscle mass and therefore a different prevalence of undernutrition. The results of our study will help to evaluate this and guide professionals in the choice of tools for assessing muscle function.
Detailed description
- Rationale 1.1 Epidemiology and morbidity of undernutrition Undernutrition, whether related to disease, poverty, hunger, war or natural disasters, affects more than one billion people worldwide (1). In France, an empirical estimate suggests a prevalence of undernutrition among hospitalized patients next to 2 million or 30 to 50%. It should be underligned that undernutrition is very common in and out of hospital. It is widely accepted that undernutrition can be caused by a deficit in nutrient intake or malabsorption. However, it is now known that the presence of an inflammatory state during illness is associated with undernutrition (1). The inflammatory state leads to anorexia and decreased intake but also increases basal metabolic rate and muscle catabolism. Undernutrition is marked by a decrease in all markers of muscle mass (1). Thus, It is strongly associated with a decrease in the patient's functional capacity and an increase in morbidity and mortality and health care costs (1,4-6). 1.2 International consensus on the definition of undernutrition In 2019, the Global Leadership Initiative on Malnutrition (GLIM) published an international consensus report on the diagnostic criteria for undernutrition (1). The diagnostic criteria are numerous, and include aetiological criteria such as reduced food intake; inflammatory context; symptoms such as anorexia, weakness; phenotypic criteria such as weight loss, body mass index (BMI), fat to lean mass ratio, fluid retention and muscle function. Muscle mass is described as a major diagnostic criterion, since it is a direct indicator of protein catabolism linked to undernutrition, but also a reflection of patient functional impairment, as it is directly associated with functional capacity, autonomy and prognosis. Various measurement tools are suggested, such as bioelectrical impedancemetry, ultrasound or magnetic resonance imaging, giving the tool choice by the clinicians, depending on experience and local resources. Handgrip measurement is considered as a complementary measure. GLIM advises an assessment of the risk of undernutrition, using validated questionnaires such as the NRS (Nutritional Risk Screening) or the MNA-SF (Mini Nutritional Assessment-Short Form). 1.3 New definition of undernutrition in France The French National Authority for Health (HAS) revised the definition of undernutrition in adults (< 70 years) in 2019, which is very similar to, but differs in some important aspects, from the GLIM definition. It includes the use of aetiological and phenotypic criteria, and now includes the assessment of muscle strength, gait speed and bioelectrical impedancemetry. 1.4 Convergences and divergences between the international and French definitions In adults under 70 years of age, both the GLIM and the HAS recommend screening for undernutrition, but the HAS recommendations do not recommend the use of a precise tool for assessing the risk of undernutrition. The presence of at least one aetiological criterion and one phenotypic criterion is mandatory to make a diagnosis of undernutrition in both situations. The differences between the international consensus and the HAS recommendations concern the diagnostic criteria. 1.5 Assessment of muscle function Physiotherapists use different tools to assess different aspects of muscle function, such as strength or walking speed. Isometric grip strength is strongly correlated with lower limb muscle strength, and is a negative marker of mobility in case of weakness (14). A linear relationship has been observed between grip strength and patient disability as measured by the Katz independence scale. In addition, grip strength has been shown to be a good predictor of the patient's clinical condition (19). The measurement of grip strength, using a dedicated dynamometer, also has the advantage of being simple and reliable and has reference values adjusted for gender and BMI. Gait speed is another indicator used to assess muscle function. It is associated with lower limb strength and is a predictor of disability and mobility limitation (14). Usual walking speed is most often measured over a distance of 4 or 6 m and has reference values adjusted for gender and height (19). Dietitians are also involved in the assessment of muscle function by measuring body composition in terms of lean body mass and fat mass. They perform bioelectrical impedancemetry, which estimates the volumes of fat and lean body mass by measuring the resistance of biological tissues to a low-intensity, high-frequency sinusoidal electric current through electrodes (14). This measurement method is simple to use, inexpensive, reproducible and feasible in bedridden patients (14). It also correlates very well with MRI and reference values are obtained in a variety of adult populations (12,22). 1.6 Research hypothesis The investigators hypothesise that the prevalence of undernutrition in a population of patients hospitalised in diabetology-obesity, pneumology, oncology and gastro-nutrition, under 70 years of age is different according to the diagnostic criteria recommended by the French National Authority for Health or those recommended by the Global Leadership Initiative on Malnutrition. Moreover, these two definitions could have a different impact on patient morbidity and mortality. The choice of the method of assessment of muscle function could impact on this prevalence.
- Objective 2.1 Main objective The main objective of this study is to compare the prevalence of global undernutrition based on the diagnostic criteria recommended by the French National Authority for Health with that based on the diagnostic criteria recommended by the Global Leadership Initiative on Malnutrition, in patients hospitalised in diabetology-obesity, pneumology, oncology and gastro-nutrition 2.2 Secondary objectives The secondary objectives will be, in patients hospitalised in diabetes-obesity, pneumology, oncology and gastro-nutrition units:
- To compare the prevalence of severe undernutrition according to the HAS and GLIM diagnostic criteria;
- To compare the morbi-mortality of moderate and severe undernutrition according to the HAS and GLIM diagnostic criteria:
- Length of hospital stay ;
- Mortality rate ;
- Autonomy at discharge.
- To compare the predictive capacity of muscle function assessment tools on undernutrition according to the HAS and GLIM diagnostic criteria.
- Type of study This is a prospective, monocenter, obversational cohort study. The research will be conducted in accordance with the protocol. The duration of recruitment will be 20 months with follow-up of patients during their entire hospital stay in the care unit, i.e. approximately 30 days (average length of stay), i.e. a total duration of the study estimated at 21 months. The study will take place at the Forcilles Hospital, in diabetology-obesity, pneumology, oncology and gastro-nutrition units.
- Usual assessment procedures 4.1 Nutritional assessment At the patient's admission, a nutrition assessment is carried out by the dietician following the recommendations issued by the French Association of Dieticians-Nutritionists (AFDN) and the HAS. The dietician collects all the data required to detect malnutrition, such as weight, height, BMI, albumin levels, as well as grip strength and walking speed (carried out by the care assistant and the physiotherapist). The dietician also looks for possible obstacles to feeding, such as dental condition, swallowing problems or digestive discomfort. The doctor looks for various pathologies affecting digestive absorption such as short stool syndromes, gastrectomies, pancreatic insufficiency etc. It also looks for factors of aggression such as cancer, chronic progressive diseases, infections etc. All of this data is used to estimate the patient's theoretical nutritional needs and to adapt the nutritional management. The dietician, in collaboration with the nurses' aides, monitors the patient's intake. 4.2 Anthropometric measurements When the patient is admitted, the nurses measure the patient's weight and height. If the patient can maintain the erect position, a conventional scale and a measuring rod are used for the measurements. If the patient cannot maintain this position, a weighing chair and a laser meter are used. In order to assess weight loss prior to hospitalisation, the previous weight is sought from a hospital report or other recent medical document. Contact with the attending physician is also made in order to obtain information about the patient's weight history. If this information is not available, the patient's previous weight is collected. 4.3 Biological measurements On admission, a biological sample is usually taken from patients at risk of undernutrition in order to measure pre-albumin, albumin and C-reactive protein (CRP). These elements make it possible to determine the severity of undernutrition when it is present, according to the diagnostic criteria of the HAS. 4.4 Muscle function measurements Measurement of grip strength ("Handgrip") 4.5 Gait speed measurement
- Assessment procedure added by the research 5.1 Mini-Nutritional Assessment Short Version (MNA-SF) score 5.2 Bio-electrical impedance measurement 5.3 Diagnosis of undernutrition according to GLIM criteria The diagnosis of undernutrition will also be carried out in the framework of this research according to the GLIM criteria. It will be based on the search for at least 1 phenotypic criterion and 1 etiological criterion. Severe undernutrition will be based solely on phenotypic criteria. This diagnosis according to the GLIM definition will be made by one of the investigators not involved in the management of the patient. The patient's team will be blinded to these results so as not to influence the management of the patient.
5 Statistical aspects 5.1 Calculation of the number of subjects required According to our internal epidemiological data, the prevalence of undernutrition according to the HAS definition was 34%. Taking into account the wider period of weight loss and the higher BMI threshold used by GLIM in its definition of undernutrition, the investigators estimate a higher prevalence of undernutrition. In the absence of data in the literature, the investigators estimate a prevalence of undernutrition according to the GLIM definition at 49%, and a difference of at least 15%. The investigators wish to highlight this discordance. With a risk α = 0.05 and a power of 80%, it will be necessary to include 260 patients.
5.2 General aspects Descriptive statistics will be based on means (+/- standard deviation) or medians [interquartile range] depending on the distribution of quantitative variables. Categorical variables will be described in terms of numbers and percentages. Univariate comparisons will use the usual statistical tests after checking the distribution of the variables (Chi2 or Fisher's test, t-test, anova or their non-parametric equivalents Wilcoxon and Kruskal-Wallis tests). Paired-sample tests will be used if necessary.
Tests will be performed at the 5% significance level. The 95% confidence intervals will be provided for each estimate.
Calculations will be made using IBM SPSS v21 and R software (version 3.6.1, http://www.R-project.org ).
5.3 Main objective The difference in the prevalence of global undernutrition between the HAS and GLIM groups will be compared using the McNemar test for comparison of proportions in matched samples.
5.4 Secondary objectives 5.4.1 Comparison of the prevalence of severe undernutrition The difference in the prevalence of severe undernutrition between the HAS and GLIM groups will be compared using the test described in the primary objective.
5.4.2 Comparison of morbidity and mortality Morbidity and mortality will be compared between the HAS and GLIM groups, for moderate and severe undernutrition, by comparing length of hospital stay, mortality and independence at discharge.
Length of hospital stay There is a relationship between the incidence of mortality and all duration type variables. Length of stay will therefore be analysed using a competitive risk method, which allows for the fact that patients who die are no longer eligible for length of stay analysis (25).
The estimator also provides the probability of in-hospital death, so that the probability of hospital discharge versus death can be assessed simultaneously at any time after inclusion in the study.
Mortality rates Mortality rates will be estimated using the Kaplan and Meier method. Comparison of the 2 curves will be performed by a Logrank test. The mortality rates in the 2 groups will be estimated via the survival curves.
ADL The ADL score will be compared between the 2 groups using the discrete numerical variable comparison tests described in the general aspects.
5.4.3 Comparison of muscle function assessment tools The impact of the choice of muscle function assessment tool will be assessed by comparing the prevalences of undernutrition diagnosed by each tool and by comparing the presence of reduced muscle mass by each tool.
6 Expected results in terms of scientific and professional advances The results of this study will make it possible to verify whether the GLIM definition increases the prevalence of undernutrition compared to that of the HAS. The use of one or other of the definitions could have an impact on the medical management of undernutrition. On the other hand, muscle function benefits from various assessment tools. These tools assess different aspects of the muscle, such as strength, functional performance or quantity. Muscle function has an important place in the new definitions of undernutrition, involving physiotherapists in addition to dieticians, nurses, care assistants and physicians in the screening for undernutrition. The different tools could lead to a different estimation of the reduction of muscle mass and thus a different prevalence of undernutrition. The results of our study will help to evaluate this and guide professionals in the choice of tools for assessing muscle function.
7 Expected benefits and risks for patients 7.1 Minimal risks and constraints added by the research All medical examinations and management are usually carried out with the exception of the MNA-SF questionnaire and bioelectrical impedancemetry, which will be carried out systematically in the patients included. The MNA-SF questionnaire is very quick (less than 5 minutes) and therefore causes very little inconvenience to the patient apart from an additional visit by a carer. Bioelectrical impedancemetry is a tool for assessing body composition using electrodes applied to the skin surface. The examination takes an average of 15 minutes, and is non-invasive and painless. The minimal stress is related to the placement of the electrode and the duration of the examination.
7.2 Expected benefits for the patient This study may highlight a difference in the prevalence of undernutrition according to the definitions and tools used. The results of this study will not provide direct benefits for the patient, but could allow the clinician to be more vigilant if undernutrition is underestimated, according to the criteria used in France. The benefit would then be a broader screening of undernutrition and would allow the adaptation of the patient's nutritional and rehabilitation management.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients will be recruited prospectively and consecutively from the departments of diabetes-obesity, pneumology, oncology and gastro-nutrition at the Forcilles Hospital. The dietician of the unit identifies the patients on admission to the department.
Key inclusion criteria (4 listed)
- Admitted to diabetes-obesity, pneumology, oncology and gastro-nutrition departments;
- Age between 18 and 70 years at the time of inclusion ;
- Affiliation with a social security scheme or beneficiary of such a scheme ;
- Oral, free, informed and express consent of the patient.
Key exclusion criteria (8 listed)
- Inability to perform bioelectrical impedance measurement ;
- Incapacity to consent ;
- Patient's refusal to participate in the study ;
- Known pregnancy ;
- Person subject to a legal protection measure ;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of global undernutrition
Time frame: Through study completion, an average of 20 months
The main outcome is the prevalence of global undernutrition in patients hospitalised in diabetes-obesity, pneumology, oncology and gastro-nutrition departments, according to the diagnostic methods of the HAS and GLIM.
7 secondary outcomes
Prevalences of severe undernutrition
Time frame: Through study completion, an average of 20 months
Duration of hospital stay
Time frame: Through study completion, an average of 20 months
Mortality
Time frame: Through study completion, an average of 20 months
Autonomy at discharge
Time frame: Through study completion, an average of 20 months
Bioelectrical impedance measurement
Time frame: Through study completion, an average of 20 months
Muscle force
Time frame: Through study completion, an average of 20 months
Walking speed
Time frame: Through study completion, an average of 20 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Sep 2026.
- Background: PubMed 30181091Cederholm T, Jensen GL, Correia MITD, Gonzalez MC, Fukushima R, Higashiguchi T, Baptista G, Barazzoni R, Blaauw R, Coats A, Crivelli A, Evans DC, Gramlich L, Fuchs-Tarlovsky V, Keller H, Llido L, Malone A, Mogensen KM, Morley JE, Muscaritoli M, Nyulasi I, Pirlich M, Pisprasert V, de van der Schueren MAE, Siltharm S, Singer P, Tappenden K, Velasco N, Waitzberg D, Yamwong P, Yu J, Van Gossum A, Compher C; GLIM Core Leadership Committee; GLIM Working Group. GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community. Clin Nutr. 2019 Feb;38(1):1-9. doi: 10.1016/j.clnu.2018.08.002. Epub 2018 Sep 3.
- Background: PubMed 12765661Correia MI, Waitzberg DL. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr. 2003 Jun;22(3):235-9. doi: 10.1016/s0261-5614(02)00215-7.
- Background: PubMed 20392703Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.
- Individual participant dataSharing planned: Yes. The protocole, the statistical analysis plan and data will be available as supplementary materials with the publication. The other data that support the findings of this study will be available from the corresponding author upon reasonable request.
Related trials for Undernutrition
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
Diabetes Mellitus, Type 2, Nutrition Poor
Active, not recruiting
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
Foot, Diabetic
Active, not recruitingPhase 2
Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
Environmental Enteric Dysfunction (EED), Stunting
Not yet recruitingObservational study
Biomarkers in EV Associated With Marrow Adiposity in Anorexia
Anorexia Nervosa Restricting Type, Anorexia Nervosa (DSM-IV Revised Criteria)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Virginie COLELLA, MSc principal investigator
Hopital Forcilles
Ilham BENHARRATS, MD study director
Hopital Forcilles
Aymeric LE NEINDRE, PhD study chair
Hopital Forcilles
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Undernutrition, run by Hopital Forcilles at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of global undernutrition (time frame: Through study completion, an average of 20 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05309759, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Sep 2026.